Efficacy and Safety of EsoDuo®

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

NCT03184324 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

NCT04282954 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis

NCT01022970 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

NCT01161602 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis

NCT04849390 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

NCT05842408 ·Status: COMPLETED ·Phase: PHASE3

Esomeprazole for Treatment of GERD in Pediatric Patients

NCT00228527 ·Status: COMPLETED ·Phase: PHASE4

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

NCT00770913 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Effect of Esomeprazole and Fundoplication on Airways

NCT00994708 ·Status: COMPLETED ·Phase: PHASE3

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

NCT02351960 ·Status: COMPLETED ·Phase: PHASE4

Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis

NCT06720610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

NCT05108038 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy of DA-5204 on Gastroesophageal Reflux Disease

NCT03998969 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

NCT06121830 ·Status: RECRUITING ·Phase: PHASE3

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

NCT01705275 ·Status: COMPLETED ·Phase: PHASE1

Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis

NCT00895817 ·Status: COMPLETED ·Phase: NA

EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone

NCT03781596 ·Status: UNKNOWN ·Phase: PHASE4

Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis

NCT01538849 ·Status: COMPLETED ·Phase: PHASE2

Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes

NCT02477475 ·Status: COMPLETED

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

NCT00786773 ·Status: COMPLETED

YM443 in Subjects With Functional Dyspepsia

NCT00102310 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

NCT05608681 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis

NCT01452776 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

NCT05660122 ·Status: COMPLETED

Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00911534 ·Status: COMPLETED ·Phase: PHASE3